US › Healthcare

Baird Medical Investment Holdings Limited (BDMD)

US · Healthcare · Medical Devices

$0.57-5.67%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$9.9M

Revenue YoY

-58.5%

Net profit

$13,499

Profit YoY

-99.8%

Net margin

0.1%

Key statistics

Market cap

$22.0M

Forward P/E

5.6

P/B

0.73

Book value

$1.09

EPS (TTM)

$-0.55

52-week high

$3.70

52-week low

$0.51

50-day MA

$1.01

200-day MA

$1.40

Beta

-1.12

Analyst view

with an average price target of $4.00.

Shareholding

Insiders

86.31%

Institutions

0.99%

Largest institutional holders

Fund	Stake
UBS Group AG	0.18%
Two Sigma Investments LLC	0.17%
Renaissance Technologies Corp	0.17%
Citadel Advisors Llc	0.17%
Jane Street Group LLC	0.10%
NATIONAL BANK OF CANADA /FI/	0.09%
Geode Capital Management, LLC	0.06%
XTX Topco Ltd	0.03%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Baird Medical Investment Holdings Limited — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.